TYSABRI (natalizumab) - Nouveaux renseignements en matière d'innocuité concernant la leucoencéphalopathie multifocale progressive (LMP) - Pour le public
Émis le 17 mai 2010
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker